Macugen (pegaptanib sodium), a novel ocular therapeutic that targets vascular endothelial growth factor (VEGF). (Q36632916)
Jump to navigation
Jump to search
scientific article published on January 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Macugen (pegaptanib sodium), a novel ocular therapeutic that targets vascular endothelial growth factor (VEGF). |
scientific article published on January 2006 |
Statements
1 reference
Macugen (pegaptanib sodium), a novel ocular therapeutic that targets vascular endothelial growth factor (VEGF). (English)
1 reference
Barrett Katz
1 reference
Mauro Goldbaum
1 reference
1 January 2006
1 reference
1 reference
46
1 reference
4
1 reference
141-154
1 reference
Identifiers
1 reference
1 reference